A Brief Report of a Phase II trial Evaluating Efficacy and Safety of Hypomethylating Agent Guadecitabine in Combination With Carboplatin in Extensive Stage Small Cell Lung Cancer.
Saved in:
| Title: | A Brief Report of a Phase II trial Evaluating Efficacy and Safety of Hypomethylating Agent Guadecitabine in Combination With Carboplatin in Extensive Stage Small Cell Lung Cancer. |
|---|---|
| Authors: | Wei CX; Department of Hematology and Oncology, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, IN., Mamdani H; Department of Oncology, Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, MI., Gentzler R; Department of Hematology and Oncology, University of Virginia Cancer Center, UVA Health, Charlottesville, VA., Kalra M; LifeBridge Health, Alvin and Lois Lapidus Cancer Institute, Baltimore, MD., Perkins S; Department of Hematology and Oncology, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, IN., Althouse S; Department of Hematology and Oncology, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, IN., Jalal SI; Department of Hematology and Oncology, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, IN. Electronic address: sjalal@iu.edu. |
| Source: | Clinical lung cancer [Clin Lung Cancer] 2023 Jun; Vol. 24 (4), pp. 347-352. Date of Electronic Publication: 2023 Mar 21. |
| Publication Type: | Clinical Trial, Phase II; Research Support, Non-U.S. Gov't; Journal Article |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 100893225 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0690 (Electronic) Linking ISSN: 15257304 NLM ISO Abbreviation: Clin Lung Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1938-0690 |
|---|---|
| DOI: | 10.1016/j.cllc.2023.03.003 |
